Folly to forecast startup performance?

Several days ago, Paul Graham, co-founder of noted Silicon Valley accelerator Y-Combinator (YC), wrote an exceptional post, "Black Swan Farming," observing how crazy difficult it is to predict success in the start-up space, and noting that just two companies - Airbnb and Dropbox - account for about 75% of the total value created by all YC-associated companies.

Yesterday, Dave McClure (the white-hot seed-stage Silicon Valley investor, familiar to readers of this column - see this discussion of his small bets style in connection with digital health) responded in a post titled (what else?) "Screw the Black Swans" that his investment model (at 500 Startups) is slightly different. 

While most VCs are looking for the big score, McClure said, he's deliberately seeking singles and doubles, which he basically expects will result in a similar expected value for his portfolio but reduce the chances of getting shut-out.  He anticipates and is hoping for a greater number of successes (albeit more modest ones) than achieved by other VCs.

This will be a familiar dialog not only to investors but also to those in biopharma (who perhaps should be thought of as investors as well), as they continuously need to decide whether to go for a risky potential blockbuster or more of a sure-thing that ostensibly may be associated with a smaller market.

I've been fascinated with this exact question for a while (see here and here), and I've always looked at the problem a bit differently than McClure - which, if I'm right, may actually be good news for him.

While robust data are difficult to come by, so much of what I've seen in the two exception-dominated spaces with which I'm most familiar - startups and in drug development - suggest that Paul Graham (and Nassim Taleb - see this recent WSJ piece arguing most successful investors are lucky not good, nicely summarized here by Business Insider) are right: success, and particularly the magnitude of success, is virtually impossible to predict. 

The folly of forecasting, if taken seriously, is a mind-blowing concept that is at once viscerally uncomfortable and operationally nearly impractical; as a result, most investors and businesses effectively ignore it, and basically (as I've discussed in perhaps my favorite piece) "assume a can opener."

Now add to the mix the well-described tendency of startups to pivot like mad, and you have a situation where I suspect it's not at all clear whether you have a potential single or homerun on your hands, even if McClure (who usually acknowledges the limitations of forecasting) believes he can accurate predict this.   Yet (as McClure certainly recognizes), many incredibly successful companies in the valley started off focused on a very narrow problem, then subsequently realized their solution or approach could be applied or redirected to a larger opportunity.

Sure, I appreciate that the idea of trying to solve huge problem seems more likely to be massively successful than if you're trying to solve a trivial problem, and I also believe that while you can't predict the magnitude of success, you can certainly increase the probability of failure - wrong team, wrong problem, even wrong advice from investors.  And let's be honest - there are a large number of entrepreneurial efforts that are overtly, painfully trivial; it's just that I don't see McClure going after them. 

Having highlighted the problems with predictions, let me go ahead and make a counter-intuitive one: in 10 years, the best performers in McClure's portfolio could very well create more value (to use Graham's standard - and note this value may or may not be realized by the seed-stage investor) than the top performers at YC.

Further Black Swan reading:

WSJ book review of The Black Swan (written before I met Taleb)

Financial Times commentary about serendipity and drug discovery (co-written with Taleb)

 

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

David
Shaywitz

What's new on AEI

AEI Election Watch 2014: What will happen and why it matters
image A nation divided by marriage
image Teaching reform
image Socialist party pushing $20 minimum wage defends $13-an-hour job listing
AEI on Facebook
Events Calendar
  • 27
    MON
  • 28
    TUE
  • 29
    WED
  • 30
    THU
  • 31
    FRI
Monday, October 27, 2014 | 10:00 a.m. – 11:30 a.m.
State income taxes and the Supreme Court: Maryland Comptroller v. Wynne

Please join AEI for a panel discussion exploring these and other questions about this crucial case.

Tuesday, October 28, 2014 | 9:30 a.m. – 12:15 p.m.
For richer, for poorer: How family structures economic success in America

Join Lerman, Wilcox, and a group of distinguished scholars and commentators for the release of Lerman and Wilcox’s report, which examines the relationships among and policy implications of marriage, family structure, and economic success in America.

Tuesday, October 28, 2014 | 5:30 p.m. – 7:00 p.m.
The 7 deadly virtues: 18 conservative writers on why the virtuous life is funny as hell

Please join AEI for a book forum moderated by Last and featuring five of these leading conservative voices. By the time the forum is over, attendees may be on their way to discovering an entirely different — and better — moral universe.

Thursday, October 30, 2014 | 2:00 p.m. – 3:00 p.m.
A nuclear deal with Iran? Weighing the possibilities

Join us, as experts discuss their predictions for whether the United States will strike a nuclear deal with Iran ahead of the November 24 deadline, and the repercussions of the possible outcomes.

Thursday, October 30, 2014 | 5:00 p.m. – 6:15 p.m.
The forgotten depression — 1921: The crash that cured itself

Please join Author James Grant and AEI senior economists for a discussion about Grant's book, "The Forgotten Depression: 1921: The Crash That Cured Itself" (Simon & Schuster, 2014).

No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled today.
No events scheduled this day.